Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin
Crossref DOI link: https://doi.org/10.1007/s40272-016-0202-4
Published Online: 2016-11-21
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buckel, Whitney R.
Ghobrial, Shahira
Tamma, Pranita D.
Milstone, Aaron M.
Zhao, Yuan
Hsu, Alice J.
License valid from 2016-11-21